Levonadifloxacin
An antibiotic used to treat bacterial infections
Levonadifloxacin is a broad-spectrum antibiotic belonging to the fluoroquinolone class, specifically designed to combat Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It is a novel therapeutic agent that has been developed to address the growing issue of antibiotic resistance.
Mechanism of Action[edit | edit source]
Levonadifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for bacterial DNA replication, transcription, repair, and recombination. By targeting these enzymes, levonadifloxacin disrupts the supercoiling of bacterial DNA, ultimately leading to bacterial cell death.
Pharmacokinetics[edit | edit source]
Levonadifloxacin is available in both oral and intravenous formulations, allowing for flexible administration depending on the clinical scenario. It exhibits good tissue penetration, which is essential for treating infections in various body sites. The drug is primarily excreted via the renal route, and dose adjustments may be necessary in patients with renal impairment.
Clinical Uses[edit | edit source]
Levonadifloxacin is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible strains of bacteria. Its efficacy against MRSA makes it a valuable option in settings where resistance to other antibiotics is prevalent.
Side Effects[edit | edit source]
Common side effects of levonadifloxacin include gastrointestinal disturbances such as nausea and diarrhea, as well as headache and dizziness. As with other fluoroquinolones, there is a risk of tendonitis and tendon rupture, particularly in older patients and those on concurrent corticosteroid therapy.
Development and Approval[edit | edit source]
Levonadifloxacin was developed as a response to the increasing need for effective treatments against resistant bacterial strains. It has undergone extensive clinical trials to establish its safety and efficacy profile. The drug has been approved for use in several countries and continues to be studied for additional indications.
Related pages[edit | edit source]
Gallery[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
